WEST PHARMACEUTICAL SERVICES, INC. Total Liabilities
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Total Liabilities of $1.09 billion as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-07-23
- 2026-06-30: Liabilities $1.09B.
- 2026-03-31: Liabilities $1.12B.
- 2025-12-31: Liabilities $1.09B.
- 2025-09-30: Liabilities $1.05B.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $1.09B 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $1.12B 10-Q · filed 2026-04-23 | |
| 2025-12-31 | $1.09B 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $1.05B 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $1.02B 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $935.10M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $961.10M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $923.00M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $912.60M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $921.70M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $948.50M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $886.50M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $922.90M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $947.40M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $931.90M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $846.00M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $937.30M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $968.50M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $978.40M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $940.30M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $900.90M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $910.70M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $939.30M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $863.90M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $786.00M 10-Q · filed 2020-07-24 | |
| 2020-03-31 | $756.30M 10-Q · filed 2020-04-24 | |
| 2019-12-31 | $768.20M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $686.40M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $678.10M 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $666.70M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $582.60M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $594.30M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $591.80M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $564.30M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $582.90M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $613.50M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $600.60M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $564.90M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $599.20M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $593.00M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $595.70M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $594.20M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $671.20M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $671.20M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $674.30M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $654.90M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $712.80M 10-K · filed 2016-02-26 | $714.00M 10-K · filed 2015-02-25 |
| 2014-09-30 | $703.20M 10-Q · filed 2014-11-03 | |
| 2014-06-30 | $732.10M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $773.60M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $765.20M 10-K · filed 2015-02-25 | |
| 2013-09-30 | $827.80M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $828.50M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $831.20M 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $835.10M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $810.30M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $783.30M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $762.60M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $744.20M 10-K · filed 2013-02-27 | |
| 2011-09-30 | $707.00M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $719.30M 10-Q/A · filed 2011-08-08 | |
| 2011-03-31 | $703.00M 10-Q · filed 2011-05-05 | |
| 2010-12-31 | $668.60M 10-K/A · filed 2012-03-01 | |
| 2010-09-30 | $667.50M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $651.10M 10-Q · filed 2010-08-05 | |
| 2009-12-31 | $691.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |